TY - JOUR
T1 - Staging of untreated nasopharyngeal carcinoma with PET/CT
T2 - Comparison with conventional imaging work-up
AU - Ng, Shu Hang
AU - Chan, Sheng Chieh
AU - Yen, Tzu Chen
AU - Chang, Joseph Tung Chieh
AU - Liao, Chun Ta
AU - Ko, Sheung Fat
AU - Liu, Feng Yuan
AU - Chin, Shu Chyn
AU - Fan, Kang Hsing
AU - Hsu, Cheng Lung
PY - 2009/1
Y1 - 2009/1
N2 - Purpose: We prospectively compared PET/CT and conventional imaging for initial staging of nasopharyngeal carcinoma (NPC). Methods: A total of 111 patients with histologically proven NPC were investigated with PET/CT and conventional imaging (head-and-neck MRI, chest X-ray, abdominal ultrasound, and bone scan) before treatment. The respective findings were reviewed independently and then compared with each other. Results: With regard to T staging, PET/CT showed a discrepancy with head-and-neck MRI in 36 (32.4%) of the study subjects. With regard to N staging, PET/CT showed a discrepancy with head-and-neck MRI in 15 (13.5%) patients. Among the discordant cases, MRI was superior in demonstrating tumor involvement in the parapharyngeal space, skull base, intracranial area, sphenoid sinus, and retropharyngeal nodes while PET/CT was superior in demonstrating neck nodal metastasis. PET/CT disclosed 13 of 16 patients with distant malignancy compared with four patients disclosed by conventional imaging work-up. The false-positive rate of PET/CT was 18.8%. PET/CT correctly modified M staging in eight patients (7.2%) and disclosed a second primary lung malignancy in one patient (0.9%). Conclusion: In NPC patients, MRI appears to be superior to PET/CT for the assessment of locoregional invasion and retropharyngeal nodal metastasis. PET/CT is more accurate than MRI for determining cervical nodal metastasis and should be the better reference for the neck status. PET/CT has an acceptable diagnostic yield and a low false-positive rate for the detection of distant malignancy and can replace conventional work-up to this aim. PET/CT and head-and-neck MRI are suggested for the initial staging of NPC patients.
AB - Purpose: We prospectively compared PET/CT and conventional imaging for initial staging of nasopharyngeal carcinoma (NPC). Methods: A total of 111 patients with histologically proven NPC were investigated with PET/CT and conventional imaging (head-and-neck MRI, chest X-ray, abdominal ultrasound, and bone scan) before treatment. The respective findings were reviewed independently and then compared with each other. Results: With regard to T staging, PET/CT showed a discrepancy with head-and-neck MRI in 36 (32.4%) of the study subjects. With regard to N staging, PET/CT showed a discrepancy with head-and-neck MRI in 15 (13.5%) patients. Among the discordant cases, MRI was superior in demonstrating tumor involvement in the parapharyngeal space, skull base, intracranial area, sphenoid sinus, and retropharyngeal nodes while PET/CT was superior in demonstrating neck nodal metastasis. PET/CT disclosed 13 of 16 patients with distant malignancy compared with four patients disclosed by conventional imaging work-up. The false-positive rate of PET/CT was 18.8%. PET/CT correctly modified M staging in eight patients (7.2%) and disclosed a second primary lung malignancy in one patient (0.9%). Conclusion: In NPC patients, MRI appears to be superior to PET/CT for the assessment of locoregional invasion and retropharyngeal nodal metastasis. PET/CT is more accurate than MRI for determining cervical nodal metastasis and should be the better reference for the neck status. PET/CT has an acceptable diagnostic yield and a low false-positive rate for the detection of distant malignancy and can replace conventional work-up to this aim. PET/CT and head-and-neck MRI are suggested for the initial staging of NPC patients.
KW - MRI
KW - Nasopharyngeal carcinoma
KW - PET/CT
KW - TNM staging
UR - https://www.scopus.com/pages/publications/57249115924
U2 - 10.1007/s00259-008-0918-7
DO - 10.1007/s00259-008-0918-7
M3 - 文章
C2 - 18704401
AN - SCOPUS:57249115924
SN - 1619-7070
VL - 36
SP - 12
EP - 22
JO - European Journal of Nuclear Medicine and Molecular Imaging
JF - European Journal of Nuclear Medicine and Molecular Imaging
IS - 1
ER -